SBRA - Sabra Health Care REIT, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$21.20
DETAILS
HIGH:
$22.00
LOW:
$19.00
MEDIAN:
$22.00
CONSENSUS:
$21.20
UPSIDE:
6.64%
AlphaVal
Deterministic, archetype-aware fair value
Real Estate Investment Trust
85% confidence
Primary model: P/FFO × Healthcare REIT Multiple
Adjust Assumptions
18.0x
$
Key Value Driver
FFO/share ($1.36) × healthcare P/FFO multiple
Implied Market Multiple
14.6x
Plain-Language Summary
Our base-case estimate uses P/FFO × Healthcare REIT Multiple. We then blend that result with the average analyst price target of $21.20 from 29 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $23.64 per share.
Warnings
Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.
Dividend yield of 6.0% is unusually high — make sure the company generates enough cash to keep paying it.
Key Risks
- P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
- Interest rate sensitivity: REIT multiples compress when rates rise
- FFO approximation (NI + D&A) may include gains on property sales — verify